Related references
Note: Only part of the references are listed.First Report of the Italian Registry on Immune-Mediated Congenital Heart Block (Lu.Ne Registry)
Micaela Fredi et al.
FRONTIERS IN CARDIOVASCULAR MEDICINE (2019)
Serial echocardiography for immune-mediated heart disease in the fetus: results of a risk-based prospective surveillance strategy
Nobuhiko Kan et al.
PRENATAL DIAGNOSIS (2017)
Outcome in 212 anti-Ro/SSA-positive pregnancies and population-based incidence of congenital heart block
Amanda Skog et al.
ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA (2016)
Fluorinated steroids do not improve outcome of isolated atrioventricular block
N. W. E. Van den Berg et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2016)
Description of 214 cases of autoimmune congenital heart block: Results of the French neonatal lupus syndrome
Kateri Levesque et al.
AUTOIMMUNITY REVIEWS (2015)
Diagnosis and Treatment of Fetal Cardiac Disease A Scientific Statement From the American Heart Association
Mary T. Donofrio et al.
CIRCULATION (2014)
Prenatal Anti-Ro Antibody Exposure, Congenital Complete Atrioventricular Heart Block, and High-Dose Steroid Therapy Impact on Neurocognitive Outcome in School-Age Children
E. N. Kelly et al.
ARTHRITIS & RHEUMATOLOGY (2014)
Long-term growth of children with autoantibody-mediated congenital heart block
Amanda Skog et al.
ACTA PAEDIATRICA (2013)
Anatomical and pathological findings in hearts from fetuses and infants with cardiac manifestations of neonatal lupus
Carolina Llanos et al.
RHEUMATOLOGY (2012)
Maternal and Fetal Factors Associated With Mortality and Morbidity in a Multi-Racial/Ethnic Registry of Anti-SSA/Ro-Associated Cardiac Neonatal Lupus
Peter M. Izmirly et al.
CIRCULATION (2011)
Isolated Atrioventricular Block in the Fetus A Retrospective, Multinational, Multicenter Study of 175 Patients
Hakan Eliasson et al.
CIRCULATION (2011)
Persistent Fetal Sinus Bradycardia Associated with Maternal Anti-SSA/Ro and Anti-SSB/La Antibodies
Priya Chockalingam et al.
JOURNAL OF RHEUMATOLOGY (2011)
Prolongation of the Atrioventricular Conduction in Fetuses Exposed to Maternal Anti-Ro/SSA and Anti-La/SSB Antibodies Did Not Predict Progressive Heart Block A Prospective Observational Study on the Effects of Maternal Antibodies on 165 Fetuses
Edgar T. Jaeggi et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2011)
Use of Intravenous Gamma Globulin and Corticosteroids in the Treatment of Maternal Autoantibody-Mediated Cardiomyopathy
Sara M. Trucco et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2011)
The Importance of the Level of Maternal Anti-Ro/SSA Antibodies as a Prognostic Marker of the Development of Cardiac Neonatal Lupus Erythematosus A Prospective Study of 186 Antibody-Exposed Fetuses and Infants
Edgar Jaeggi et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
Research electronic data capture (REDCap)-A metadata-driven methodology and workflow process for providing translational research informatics support
Paul A. Harris et al.
JOURNAL OF BIOMEDICAL INFORMATICS (2009)
Congenital Heart Block Not Associated with Anti-Ro/La Antibodies: Comparison with Anti-Ro/La-positive Cases
Antonio Brucato et al.
JOURNAL OF RHEUMATOLOGY (2009)
Perinatal outcome of fetal atrioventricular block - One-hundred-sixteen cases from a single institution
Lilian M. Lopes et al.
CIRCULATION (2008)
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices) Developed in Collaboration With the American Association for Thoracic Surgery and Society of Thoracic Surgeons
Andrew E. Epstein et al.
CIRCULATION (2008)
Atrial and ventricular rate response and patterns of heart rate acceleration during maternal-fetal terbutaline treatment of fetal complete heart block
Bettina F. Cuneo et al.
AMERICAN JOURNAL OF CARDIOLOGY (2007)
Normal neuropsychological development in children with congenital complete heart block who may or may not be exposed to high-dose dexamethasone in utero
A. Brucato et al.
ANNALS OF THE RHEUMATIC DISEASES (2006)
Presentation and prognosis of complete atrioventricular block in childhood, according to maternal antibody status
Elisabeth Villain et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2006)
Transient non-autoimmune fetal heart block
JMPJ Breur et al.
FETAL DIAGNOSIS AND THERAPY (2005)
Transplacental fetal treatment improves the outcome of prenatally diagnosed complete atrioventricular block without structural heart disease
ET Jaeggi et al.
CIRCULATION (2004)
Prospective echocardiograpic evaluation of atrioventricular conduction in fetuses with maternal Sjogren's antibodies
AH Van Bergen et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2004)
Endocardial fibroelastosis associated with maternal anti-Ro and anti-La antibodies in the absence of atrioventricular block
LE Nield et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2002)
Maternal anti-Ro and anti-La antibody-associated endocardial fibroelastosis
LE Nield et al.
CIRCULATION (2002)
Spectrum and progression of conduction abnormalities in infants born to mothers with anti-SSA/Ro-SSB/La antibodies
AD Askanase et al.
LUPUS (2002)
A new and improved population-based Canadian reference for birth weight for gestational age
MS Kramer et al.
PEDIATRICS (2001)
Dilated cardiomyopathy in isolated congenital complete atrioventricular block: Early and long-term risk in children
FEAU ten Cate et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2001)
Congenital heart block: Development of late-onset cardiomyopathy, a previously underappreciated sequela
JP Moak et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2001)
Share Paper
